- Presentations
- 2
- Markets
- 1
Xeljanz XR is a brand of Tofacitinib marketed by Pfizer Laboratories, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Tofacitinib
- Brand owner
- Pfizer Laboratories
- Registered in
- United States
- Strengths and forms
- 11 mg extended-release tablet, 22 mg extended-release tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Xeljanz XR 11 mg extended-release tabletOral | Pfizer Laboratories | US FDA | Available on request |
| Xeljanz XR 22 mg extended-release tabletOral | Pfizer Laboratories | US FDA | Available on request |
Equivalent brands
Other brands of Tofacitinib.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Xeljanz XR
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.